134 related articles for article (PubMed ID: 22336910)
1. Myriocin, a serine palmitoyltransferase inhibitor, suppresses tumor growth in a murine melanoma model by inhibiting de novo sphingolipid synthesis.
Lee YS; Choi KM; Lee S; Sin DM; Lim Y; Lee YM; Hong JT; Yun YP; Yoo HS
Cancer Biol Ther; 2012 Jan; 13(2):92-100. PubMed ID: 22336910
[TBL] [Abstract][Full Text] [Related]
2. Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest.
Lee YS; Choi KM; Choi MH; Ji SY; Lee S; Sin DM; Oh KW; Lee YM; Hong JT; Yun YP; Yoo HS
Cell Prolif; 2011 Aug; 44(4):320-9. PubMed ID: 21645154
[TBL] [Abstract][Full Text] [Related]
3. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.
Park TS; Rosebury W; Kindt EK; Kowala MC; Panek RL
Pharmacol Res; 2008 Jul; 58(1):45-51. PubMed ID: 18611440
[TBL] [Abstract][Full Text] [Related]
4. Myriocin, a serine palmitoyltransferase inhibitor, blocks cytokinesis in Leishmania (Viannia) braziliensis promastigotes.
Castro EV; Yoneyama KG; Haapalainen EF; Toledo MS; Takahashi HK; Straus AH
J Eukaryot Microbiol; 2013; 60(4):377-87. PubMed ID: 23659342
[TBL] [Abstract][Full Text] [Related]
5. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
[TBL] [Abstract][Full Text] [Related]
6. Myriocin, an inhibitor of serine palmitoyl transferase, impairs the uptake of transferrin and low-density lipoprotein in mammalian cells.
Meyer SG; Wendt AE; Scherer M; Liebisch G; Kerkweg U; Schmitz G; de Groot H
Arch Biochem Biophys; 2012 Oct; 526(1):60-8. PubMed ID: 22841978
[TBL] [Abstract][Full Text] [Related]
7. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.
Miyake Y; Kozutsumi Y; Nakamura S; Fujita T; Kawasaki T
Biochem Biophys Res Commun; 1995 Jun; 211(2):396-403. PubMed ID: 7794249
[TBL] [Abstract][Full Text] [Related]
8. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice.
Lee BJ; Kim JS; Kim BK; Jung SJ; Joo MK; Hong SG; Kim JS; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT; Yoo HS; Oh S
J Gastroenterol Hepatol; 2010 Jun; 25(6):1105-10. PubMed ID: 20594226
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of serine palmitoyltransferase by myriocin, a natural mycotoxin, causes induction of c-myc in mouse liver.
He Q; Johnson VJ; Osuchowski MF; Sharma RP
Mycopathologia; 2004 Apr; 157(3):339-47. PubMed ID: 15180163
[TBL] [Abstract][Full Text] [Related]
11. Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations.
Johnson VJ; He Q; Osuchowski MF; Sharma RP
Toxicology; 2004 Sep; 201(1-3):67-75. PubMed ID: 15297021
[TBL] [Abstract][Full Text] [Related]
12. Plasma membrane effects of sphingolipid-synthesis inhibition by myriocin in CHO cells: a biophysical and lipidomic study.
Monasterio BG; Jiménez-Rojo N; García-Arribas AB; Riezman H; Goñi FM; Alonso A
Sci Rep; 2022 Jan; 12(1):955. PubMed ID: 35046440
[TBL] [Abstract][Full Text] [Related]
13. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
He Q; Riley RT; Sharma RP
Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipid synthesis is involved in autophagy in Saccharomyces cerevisiae.
Yamagata M; Obara K; Kihara A
Biochem Biophys Res Commun; 2011 Jul; 410(4):786-91. PubMed ID: 21703229
[TBL] [Abstract][Full Text] [Related]
15. The essential structures of ISP-I that influence serine palmitoyltransferase inhibition in Chinese hamster ovary cells.
Mizukoshi K; Matsumoto K; Hirose R; Fujita T
Biol Pharm Bull; 2012; 35(8):1349-53. PubMed ID: 22863936
[TBL] [Abstract][Full Text] [Related]
16. De novo sphingolipid synthesis is essential for viability, but not for transport of glycosylphosphatidylinositol-anchored proteins, in African trypanosomes.
Sutterwala SS; Creswell CH; Sanyal S; Menon AK; Bangs JD
Eukaryot Cell; 2007 Mar; 6(3):454-64. PubMed ID: 17220466
[TBL] [Abstract][Full Text] [Related]
17. Myriocin, a serine palmitoyltransferase inhibitor, alters regional brain neurotransmitter levels without concurrent inhibition of the brain sphingolipid biosynthesis in mice.
Osuchowski MF; Johnson VJ; He Q; Sharma RP
Toxicol Lett; 2004 Feb; 147(1):87-94. PubMed ID: 14700532
[TBL] [Abstract][Full Text] [Related]
18. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Inhibition of Serine Palmitoyl Transferase and Sphingosine Kinase-1/-2 Inhibits Merkel Cell Carcinoma Cell Proliferation.
Bhat VK; Bernhart E; Plastira I; Fan K; Ghaffari-Tabrizi-Wizsy N; Wadsack C; Rechberger G; Eichmann T; Asslaber M; Spassova I; Verhaegen ME; Malle E; Becker JC; Sattler W
J Invest Dermatol; 2019 Apr; 139(4):807-817. PubMed ID: 30399362
[TBL] [Abstract][Full Text] [Related]
20. Myriocin, a serine palmitoyltransferase inhibitor, increases melanin synthesis in Mel-Ab cells and a skin equivalent model.
Li H; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
Pharmazie; 2014 Mar; 69(3):187-91. PubMed ID: 24716407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
